
Lynn Y. Fan
Examiner (ID: 12264, Phone: (571)270-3541 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1759, 1651 |
| Total Applications | 625 |
| Issued Applications | 239 |
| Pending Applications | 111 |
| Abandoned Applications | 293 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20451836
[patent_doc_number] => 12514880
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Amniotic fluid composition and method of using
[patent_app_type] => utility
[patent_app_number] => 17/717479
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 1995
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17717479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/717479 | Amniotic fluid composition and method of using | Apr 10, 2022 | Issued |
Array
(
[id] => 19219153
[patent_doc_number] => 20240183857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => Protein Tyrosine Phosphatases as Biomarkers for Hepatocellular Carcinoma and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/553044
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553044
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/553044 | Protein Tyrosine Phosphatases as Biomarkers for Hepatocellular Carcinoma and Uses Thereof | Mar 28, 2022 | Pending |
Array
(
[id] => 17895306
[patent_doc_number] => 20220304968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => OXIDATIVE RETINAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/705708
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24504
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705708
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705708 | OXIDATIVE RETINAL DISEASES | Mar 27, 2022 | Abandoned |
Array
(
[id] => 18019075
[patent_doc_number] => 20220370574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => BOTULINUM NEUROTOXINS FOR TREATING HYPERHIDROSIS
[patent_app_type] => utility
[patent_app_number] => 17/656071
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17656071
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/656071 | BOTULINUM NEUROTOXINS FOR TREATING HYPERHIDROSIS | Mar 22, 2022 | Abandoned |
Array
(
[id] => 19280007
[patent_doc_number] => 20240216480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => TREATMENT OF EYE DISEASES WITH FRUCTOSYL-AMINO ACID OXIDASE
[patent_app_type] => utility
[patent_app_number] => 18/549476
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549476
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/549476 | TREATMENT OF EYE DISEASES WITH FRUCTOSYL-AMINO ACID OXIDASE | Mar 6, 2022 | Pending |
Array
(
[id] => 19156135
[patent_doc_number] => 20240148842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => PROTEOLYTIC ENZYME MIXTURE FOR TREATING PSORIASIS
[patent_app_type] => utility
[patent_app_number] => 18/548385
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548385
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548385 | PROTEOLYTIC ENZYME MIXTURE FOR TREATING PSORIASIS | Feb 28, 2022 | Abandoned |
Array
(
[id] => 20039238
[patent_doc_number] => 20250177460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => AGENT FOR IMPROVING FEMALE MENOPAUSAL SYMPTOM
[patent_app_type] => utility
[patent_app_number] => 18/842563
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18842563
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/842563 | AGENT FOR IMPROVING FEMALE MENOPAUSAL SYMPTOM | Feb 28, 2022 | Pending |
Array
(
[id] => 19218236
[patent_doc_number] => 20240182940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => Enhanced Sophorolipid Derivatives
[patent_app_type] => utility
[patent_app_number] => 17/776729
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776729
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776729 | Enhanced Sophorolipid Derivatives | Feb 14, 2022 | Pending |
Array
(
[id] => 17838919
[patent_doc_number] => 20220276224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => DEVICE, METHOD AND SYSTEM FOR MONITORING IMMUNE SYSTEM RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/668108
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17668108
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/668108 | DEVICE, METHOD AND SYSTEM FOR MONITORING IMMUNE SYSTEM RESPONSE | Feb 8, 2022 | Pending |
Array
(
[id] => 19752800
[patent_doc_number] => 20250041365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => PROBIOTIC COMPOSITIONS AND MICROBIAL CONSORTIA TO IMPROVE HUMAN ORGAN SYSTEM HEALTH
[patent_app_type] => utility
[patent_app_number] => 18/836553
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18836553
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/836553 | PROBIOTIC COMPOSITIONS AND MICROBIAL CONSORTIA TO IMPROVE HUMAN ORGAN SYSTEM HEALTH | Feb 6, 2022 | Pending |
Array
(
[id] => 18034519
[patent_doc_number] => 20220378734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => NEURODEGENERATIVE DISORDERS AND MUSCLE DISEASES IMPLICATING PUFAS
[patent_app_type] => utility
[patent_app_number] => 17/665436
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26061
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665436
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/665436 | NEURODEGENERATIVE DISORDERS AND MUSCLE DISEASES IMPLICATING PUFAS | Feb 3, 2022 | Pending |
Array
(
[id] => 17593541
[patent_doc_number] => 20220143114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => ACTIVE SUBSTANCE OF LACTOBACILLUS PLANTARUM GKM3, A COMPOSITION COMPRISING THEREOF AND ITS USE FOR PROMOTING LONGEVITY
[patent_app_type] => utility
[patent_app_number] => 17/583859
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583859
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/583859 | Active substance of | Jan 24, 2022 | Issued |
Array
(
[id] => 17576960
[patent_doc_number] => 20220133815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => MUSCLE-MODIFYING AGENT
[patent_app_type] => utility
[patent_app_number] => 17/575897
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17575897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/575897 | MUSCLE-MODIFYING AGENT | Jan 13, 2022 | Abandoned |
Array
(
[id] => 17579051
[patent_doc_number] => 20220135906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => Use of Polypeptides
[patent_app_type] => utility
[patent_app_number] => 17/574668
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574668
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/574668 | Use of Polypeptides | Jan 12, 2022 | Pending |
Array
(
[id] => 18901496
[patent_doc_number] => 20240016981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => REGENERATIVE TISSUE MANUFACTURING PROCESS
[patent_app_type] => utility
[patent_app_number] => 18/256867
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256867
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/256867 | REGENERATIVE TISSUE MANUFACTURING PROCESS | Dec 8, 2021 | Pending |
Array
(
[id] => 18924474
[patent_doc_number] => 20240027478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => TREATMENT OF HEMOPHILIA WITH FITUSIRAN
[patent_app_type] => utility
[patent_app_number] => 18/256199
[patent_app_country] => US
[patent_app_date] => 2021-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256199
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/256199 | TREATMENT OF HEMOPHILIA WITH FITUSIRAN | Dec 5, 2021 | Pending |
Array
(
[id] => 17957884
[patent_doc_number] => 20220338464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => LUNG PERFUSION SOLUTION, AND USE THEREOF FOR THE EX-VIVO PRESERVATION OF A MAMMALIAN LUNG
[patent_app_type] => utility
[patent_app_number] => 17/541511
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541511
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/541511 | Lung perfusion solution, and use thereof for the ex-vivo preservation of a mammalian lung | Dec 2, 2021 | Issued |
Array
(
[id] => 18896488
[patent_doc_number] => 20240011973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => METHOD FOR PRODUCING TWO-DIMENSIONAL SMALL INTESTINAL ORGANOIDS HAVING VILLUS STRUCTURE
[patent_app_type] => utility
[patent_app_number] => 18/039534
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039534
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/039534 | METHOD FOR PRODUCING TWO-DIMENSIONAL SMALL INTESTINAL ORGANOIDS HAVING VILLUS STRUCTURE | Dec 2, 2021 | Pending |
Array
(
[id] => 18901419
[patent_doc_number] => 20240016904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => METHODS OF TREATING SUPERFICIAL DIGITAL FLEXOR TENDON INJURIES, DEEP AND SUPERFICIAL MUSCLE/TENDON CONTRACTURE, NAVICULAR SYNDROME, AND SUSPENSORY LIGAMENT INFLAMMATION AND INJURIES IN QUADRUPED ANIMALS
[patent_app_type] => utility
[patent_app_number] => 18/254582
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254582
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/254582 | METHODS OF TREATING SUPERFICIAL DIGITAL FLEXOR TENDON INJURIES, DEEP AND SUPERFICIAL MUSCLE/TENDON CONTRACTURE, NAVICULAR SYNDROME, AND SUSPENSORY LIGAMENT INFLAMMATION AND INJURIES IN QUADRUPED ANIMALS | Nov 23, 2021 | Abandoned |
Array
(
[id] => 18842646
[patent_doc_number] => 20230405050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => COMPOSITION FOR TREATING INFECTIOUS DISEASES, COMPRISING EXOSOMES DERIVED FROM THROMBIN-TREATED STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/036474
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18036474
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/036474 | COMPOSITION FOR TREATING INFECTIOUS DISEASES, COMPRISING EXOSOMES DERIVED FROM THROMBIN-TREATED STEM CELLS | Nov 22, 2021 | Pending |